H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

Published
11 May 2026
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]

The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.

View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts